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Abstract 
This study was designed to test the hypothesis that whether the plasma level of advanced oxidant protein products 
(AOPPs) would be useful for the clinical diagnosis of acute lung injury (ALI) following cardiac surgery with the tech-
nique of cardiopulmonary bypass (CPB). In this prospective study, seventy consecutive adults undergoing open heart 
surgery with CPB were included and assigned into the ALI (n = 18) and non-ALI (n = 52) groups according to the 
American-European Consensus Criteria. Plasma concentrations of AOPPs were measured at baseline, postoperative 
1 h, 12 h, 24 h, and 48 h. Eighteen patients (25.7 %) developed ALI after surgery. The plasma levels of AOPPs in the ALI 
group were significantly increased and remained considerably higher at all time points after operation (all P < 0.05). 
Multivariate logistic regression analysis revealed that the plasma level of AOPPs at 1 h after operation was an inde-
pendent predictor for the diagnosis of ALI (OR 1.164; 95 % CI 1.068–1.269; P = 0.001). Plasma level of AOPPs could 
serve as an early biomarker of the incidence of ALI in adult patients who underwent open cardiac surgery with the 
technique of CPB.
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Background
Acute lung injury (ALI) is a common complication in 
patients undergoing cardiac surgery with the technique 
of cardiopulmonary bypass (CPB) with a high morbidity 
and mortality (Vlaar et al. 2011; Apostolakis et al. 2010; 
Koch et al. 2009; Stephens et al. 2013). If ALI evolved into 
acute respiratory distress syndrome (ARDS), the mor-
tality of ALI may be as high as 80  % (Koch et  al. 2009; 
Stephens et  al. 2013; Ng et  al. 2002). ALI complication 
could prolong the length of intensive care unit (ICU) and 
hospital stay, and raise treatment expenses (Kogan et al. 
2014). In spite of widespread studies, no effective therapy 
can accelerate the recovery. Predicting ALI/ARDS would 
be extremely valuable for making clinical decisions and 
guiding subsequent research.
The incidence of ALI/ARDS following CPB was asso-
ciated with multiple overlapping biological pathways, 
cell and tissue injury, which may generate a large quan-
tity of potential biomarkers (Levitt et  al. 2009). Ideal 
biomarkers could be used to identify pivotal biologi-
cal pathways underlying the pathogenesis of ALI/ARDS 
and played a vital role in the early diagnosis of this dis-
order. Unfortunately, biomarkers remained largely a 
research tool over the past two decades. Previous stud-
ies have demonstrated that oxidative stress contributes 
to the progression of ALI/ARDS induced by different 
causes, such as CPB, sepsis, trauma and multiple trans-
fusions, etc. (Uchida et al.2006; Calfee et al. 2008; Chow 
et  al. 2003). Pulmonary oxidant production can lead to 
the incidence of ALI and occasionally progressive lung 
injury (Chow et al. 2003; Ward 2010). One of the pivotal 
mechanisms of ALI/ARDS after CPB is oxidative injury 
to the lung mediated by reactive oxygen species (ROS) 
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including superoxide anion radical (O2−), hydrogen per-
oxide (H2O2), hydroxyl radical (OH−), and hypochlorous 
acid (HOCl) (Ward 2010). ROS can lead to cell injury 
via protein oxidation that alters protein activity, causing 
release of proteases and inactivation of antioxidant and 
anti-protease enzymes (Chow et  al. 2003; Ward 2010; 
Tuinman et  al. 2013). Accumulated experimental evi-
dence supported that HOCl may lead to irreversible lung 
damage and even fibrosis (Chow et al. 2003; Ward 2010; 
Tuinman et al. 2013; Johnson and Koval 2009). Advanced 
oxidation protein products (AOPPs) are generated as a 
result of the reaction between plasma proteins and chlo-
rinated oxidants, such as chloramines and HOCl (Wu 
et  al. 2015). More importantly, AOPPs are utilized not 
only as a biomarker of oxidative stress but also a media-
tor of inflammation, which potentially reflects multiple 
aspects of the pathogenesis and pathophysiology of ALI/
ARDS following CPB (Liang et  al. 2012; Gangemi et  al. 
2015; Bochi et  al. 2014). These modified molecules may 
efficiently monitor the progression and outcome of ALI/
ARDS induced by CPB. Hence, we hypothesized that 
AOPPs would be useful for biological confirmation of the 
clinical diagnosis of ALI/ARDS following cardiac surgery 
with CPB.
The aim of this prospective study was to examine the 
plasma levels of AOPPs in patients with ALI following 
cardiac surgery and explore whether these molecules 




This prospective study was performed in Nanfang Hos-
pital affiliated to Southern Medical University, China. 
Inclusion criteria should be met if seventy patients 
aged >18 years undergoing cardiac surgery with CPB at 
our department between January and May 2014 were 
included in this clinical trial. The study protocols were 
approved by the Ethics Committee of Nanfang Hospital 
of Southern Medical University. Informed consents were 
obtained from all participants included in this study. 
Exclusion criteria: Patients were excluded if they were 
with abnormal liver or renal function, pulmonary inflam-
mation before surgery, pulmonary edema due to cardiac 
dysfunction or died from cardiac dysfunction.
Data collection
Demographic data, preoperative risk factors, and periop-
erative surgical and anesthetic management data includ-
ing the patient’s gender, age, body mass index (BMI), 
pulse oximetry saturation (SpO2), CPB time and Clamp 
time and arterial partial pressure of oxygen to fraction of 
inspired oxygen(PaO2/FiO2), length of surgery intensive 
care unit (SICU) stay and hospital stay were collected. A 
pulmonary artery catheter was inserted into all patients 
before operation. CPB was performed under mild to 
moderate hypothermia (28–34  °C) in all patients. Chest 
radiograph was routinely taken before surgery and every 
day after surgery. Echocardiography was performed rou-
tinely to evaluate postoperative cardiac function at any 
time if necessary. Left ventricular function was evaluated 
by the index of ejection fraction (EF).
Main definitions
Patients were categorized into the ALI (n = 18) and non-
ALI groups (n  =  52) according to American-European 
Consensus Conference (AECC) definition (Bernard et al. 
1994). ALI was defined as follows: oxygenation: PaO2/
FiO2 <300  mmHg (regardless of positive end-expiratory 
pressure); chest radiograph: bilateral infiltrates seen on 
frontal chest radiograph, pulmonary artery occlusion 
pressure:<18 mmHg, the absence of cardiogenic pulmo-
nary edema (CPE). CPE was identified when the pulmo-
nary arterial occlusion pressure was >18 mmHg or by the 
presence of central venous pressure >14 mmHg and left 
ventricular EF < 45 %.
Determination of plasma AOPPs
For each patient, serial plasma samples were obtained 
at the baseline level, 1, 12, 24, and 48  h after operation 
and stored at −80 °C. In previous reports, plasma AOPPs 
were determined using the semi-automated method 
(Lentini et al. 2010). In test wells, a portion of 200 μL of 
plasma was diluted to a ratio of 1:5 in phosphate-buffered 
saline (PBS), placed into a 96-well microtiter plate, and 
supplemented with 20 μL of acetic acid. In standard wells, 
10 μL of potassium iodide was added to 200 μL of chlora-
mine-T solution (0–100 μmol/L) and followed by 20 μL 
of acetic acid. The absorbance value was immediately 
measured at a wavelength of 340 nm. The concentration 
of AOPPs was expressed in unit of μmol/L of chloramine-
T equivalents. Laboratory operators were blinded to the 
ALI patients, and relevant investigators involved in the 
interpretation of ALI were blinded to AOPPs levels.
Statistical analysis
All statistical analyses were performed with SPSS 19.0 
for Windows (SPSS Inc., Chicago, IL, USA). Continuous 
data were analyzed for normal distribution with one-
sample Kolmogorov–Smirnov test. Normally-distributed 
data were further analyzed using unpaired student’s t 
test. Abnormally-distributed data were analyzed using 
Mann–Whitney U test. χ2 test was employed to compare 
categorical data as appropriate. A multivariate analysis 
of variance procedure (MANOVA) was used to assess 
whether a significant difference existed in the assessment 
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of AOPPs levels between two groups. Receiver operat-
ing characteristic curve (ROC) was computed, and area 
under the curve (AUC) was calculated to evaluate the sig-
nificance of these biomarkers in diagnosing ALI. Risk fac-
tors related to the development of ALI, such as age, sex, 
body mass index (BMI), CPB time or clamp time, were 
introduced into the univariate analysis. Multivariate step-
wise forward logistic regression analysis was then per-
formed for statistically significant univariate predictors 
to determine the independent risk factor for ALI after 
CPB. P < 0.05 was accepted as statistically significant.
Results
Demographic characteristics
A total of 70 patients fulfilled the inclusion criteria. 
Among them, 18 (25.7 %) developed ALI. Demographic 
and perioperative characteristics of all participants are 
illustrated in Table 1. Age, BMI, smoking, diabetes mel-
litus, cardiothoracic ratio, LVEF, operation type, CPB 
time, clamp time and preoperative AOPPs did not sig-
nificantly differ between two groups. However, the inci-
dence of COPD, hypertension and the proportion of 
male were significantly increased in patients with ALI 
compared with non-ALI counterparts. In addition, the 
duration of SICU stay and hospital stay were significantly 
prolonged in the ALI group compared with those in the 
non-ALI group. The first significant decline of PaO2:FiO2 
ratio occurred at 1 h after operation (Fig. 1). The ratio of 
PaO2:FiO2 at postoperative 12, 24 and 48  h in the ALI 
group was significantly lower than that in the non-ALI 
group, as illustrated in Table  2 and Fig.  1. Interestingly, 
PaO2:FiO2 ratio in the ALI group decreased to lowered 
than 300 (270 ± 43.1) at 24 h after operation.
Plasma AOPPs
For all patients, postoperative plasma levels of AOPPs 
were increased compared to the baseline level (Fig.  2). 
Plasma concentration of AOPPs was shown in Table  3. 
The levels of plasma AOPPs were first significantly 
increased at 1 h after operation and declined at postop-
erative 12 h in all patients. The levels of plasma AOPPs 
in the ALI group were significantly higher than those in 
the non-ALI group at 1, 12, 24 and 48 h after operation. 
Plasma level of AOPPs in non-ALI patients decreased 
to the baseline level, whereas those in ALI counterparts 
remained higher than the baseline level at 24  h after 
Table 1 Demographic and clinical characteristics between ALI and non-ALI patients
Data are presented as number of patients (%), mean ± SD, or counts, as appropriate
ALI acute lung injury, COPD chronic obstructive pulmonary disease, LVEF left ventricular ejection fraction, CPB cardiopulmonary bypass, SICU surgery intensive care 
unit
ALL (n = 70) ALI (n = 18) Non-ALI (n = 52) P value
Basic parameters
 Male (n) 37 12 25 <0.001
 Age (years) 47.9 ± 11.3 57.7 ± 11.6 46.6 ± 11.4 0.105
 Body mass index 21.6 ± 3.60 22.9 ± 2.90 21.1 ± 3.8 0.081
 Smoking (n) 15 6 9 0.153
 COPD (n) 7 5 2 0.01
 Hypertension (n) 9 6 3 0.007
 Diabetes mellitus (n) 4 3 1 0.05
 Cardiothoracic ratio 0.61 ± 0.09 0.63 ± 0.08 0.61 ± 0.1 0.415
 LVEF(%) 59.9 ± 7.0 57.9 ± 6.5 60.6 ± 7.1 0.154
Intraoperative parameters
 Type of surgery 0.223
  Coronary artery disease (%) 11 (15.7 %) 5 (27.8 %) 6 (11.5 %)
  Valve heart disease (%) 52 (74.3 %) 12 (66.7 %) 40 (77.0 %)
  Congenital heart disease (%) 7 (10 %) 1 (5.5 %) 6 (11.5 %)
 CPB time (min) 106.4 ± 37.8 116.3 ± 31.5 102.9 ± 39.4 0.198
 Clamp time (min) 68.5 ± 30.8 73.3 ± 24 66.9 ± 32.9 0.452
Peri-operative risk factors
 Preoperative AOPPs (μmol/L) 46.0 ± 10.5 47.1 ± 7.9 44.8 ± 10.8 0.394
 SICU stay (days) 3 (2, 5) 7.3 ± 4.4 3 (2, 3) <0.001
 Hospital stay (days) 17.3 ± 5.9 24.4 ± 5.8 14.8 ± 3.4 <0.001
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operation (Table  3; Fig.  2). In the ALI group, the level 
of AOPPs peaked at postoperative 1  h, dramatically 
decreased at 12 h after operation, and began to increase 
at postoperative 24 h after operation.
Plasma AOPPs as a predictor for ALI progression
Univariate analysis demonstrated that plasma level of 
AOPPs at 1 h after operation (OR 1.148; 95 % CI 1.065–
1.237; P  <  0.001), age (OR 1.103; 95  % CI 1.041–1.168; 
P  =  0.001), COPD (OR 9.615; 95  % CI 1.671–55.314; 
P  =  0.011), hypertension (OR 8.167; 95  % CI 1.781–
37.449; P  =  0.007) were significantly associated with 
increased risk of ALI.
After adjustment for age, diabetes mellitus and hyper-
tension by multivariable logistic analysis, plasma level 
of AOPPs at 1  h after operation (OR 1.1674; 95  % CI 
1.068–1.269; P = 0.001) and COPD (OR 28.706; 95 % CI 
1.770–465.640; P  =  0.018) were highly associated with 
increased risk of ALI (Table 4). As Fig. 3 illustrated, the 
area under the ROC curve of plasma level of AOPPs at 
postoperative 1  h was calculated as 0.875, indicating 
the clinical significance of plasma level of AOPPs at 1 h 
after operation in the diagnosis of ALI. Derived sensi-
tivity, specificity, and predictive cutoff value of plasma 
level of AOPPs at postoperative 1 h are listed in Table 5. 
Plasma level of AOPPs at 1 h after operation yielded the 
highest sensitivity and specificity at the cutoff value of 
81.89 μmol/L (Table 5).
Discussion
It is well known that the production of oxidants within 
the lung can lead to the incidence of ALI, reversible or 
even irreversible progressive lung injury (Ward 2010; 
Johnson and Koval 2009). Reversibility occurs when 
the stimulus of intrapulmonary oxidants overcomes the 
limit of natural antioxidant enzymes in the lung. Stress-
induced alterations in the conformation or structure of 
proteins are capable of inducing protein dysfunction or 
inhibiting protein degradation (Chow et al. 2003). Mod-
ified proteins can subsequently induce cellular dysfunc-
tions and tissue damage. Under such conditions, the 
regenerative capacity of the lung is overwhelmed, which 
promotes the development of ALI/ARDS (Apostolakis 
et al. 2010). AOPPs are relatively stable molecules that 
can be measured by fast and inexpensive techniques, 
which makes AOPPs as suitable biomarkers for moni-
toring oxidative stress (Bochi et al. 2014). Previous stud-
ies provided evidence that the levels of oxidative stress 
in patients receiving off-pump operations were signifi-
cantly lower compared with those in the counterparts 
undergoing CPB surgery (Matata et  al. 2000). In this 
investigation, plasma AOPPs levels were elevated after 
cardiac surgery with CPB and directly associated with 
Fig. 1 The ratio of PaO2 and FiO2 at baseline level and different time 
points after operation. Error bar are SD
Table 2 The ratio of PaO2 and FiO2 at baseline level and different time points after operation
Data were shown as mean ± SD
ALI acute lung injury
a P < 0.05 versus Non-ALI group at the same time point
PaO2:FiO2 ratio Before operation 1 h after operation 12 h after operation 24 h after operation 48 h after operation
ALI 418 ± 29.5 365 ± 31.6 314 ± 40.2a 270 ± 43.1a 256 ± 48.2a
Non-ALI 431 ± 25.4 380 ± 21.9 350 ± 22.0 331 ± 22.0 324 ± 47.7
Fig. 2 Mean plasma concentration of AOPPs at baseline level and 
different time points after operation. Error bar are SD
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the occurrence of ALI and a poor clinical outcome, 
validating the hypothesis that plasma AOPPs is a reli-
able biomarker of the risk of ALI following cardiac sur-
gery. Furthermore, the AOPPs levels in the ALI group 
were significantly higher than those in the non-ALI 
group at 1, 12, 24 and 48 h after operation, suggesting 
that plasma AOPPs levels may serve as a reliable pre-
dictor for the progression of ALI following CPB in adult 
patients.
Dynamic detection of the plasma levels of AOPPs 
was performed at 1, 12, 24 and 48 h. The plasma lev-
els of AOPPs in all patients peaked quickly at 1 h after 
operation, and then dropped to the baseline level at 
postoperative 12 h. At 24 h after surgery, the levels of 
plasma AOPPs in the ALI patients increased again and 
were maintained significantly higher compared with 
those in the non-ALI counterparts. The elevation in 
the plasma AOPPs levels may reflect the duration of 
excessive oxidative stress. Meanwhile, PaO2:FiO2 ratio 
decreased at 12  h after operation, and then declined 
to <300, which was considered as the diagnostic level 
of ALI at postoperative 24  h. Thus, plasma levels of 
AOPPs at 1  h after operation served as the first pre-
dictor of the incidence of ALI. The cutoff value of 
AOPPs was calculated as 81.89 μmol/L. There is grow-
ing evidence that increased oxidative stress ultimately 
induces endogenous defense mechanisms and inhibi-
tory responses through negatively modulating cellular 
signaling pathways (Ward 2010). Understanding the 
dynamic interaction between intrapulmonary oxidant 
production and engagement of antioxidant defenses 
provides supplementary information relevant to the 
incidence of ALI/ARDS following CPB.
Table 3 Plasma AOPPs (μmol/L) at baseline level and different time points after operation
Data were shown as mean ± SD
ALI acute lung injury
a P < 0.05 versus Non-ALI group at the same time point
AOPPs Before operation 1 h after operation 12 h after operation 24 h after operation 48 h after operation
ALI 55.7 ± 11.3 97.9 ± 15.3a 66.8 ± 21.2a 82.8 ± 26.2a 71.8 ± 20.2a
Non-ALI 44.8 ± 10.8 68.2 ± 10.7 53.6 ± 17.1 48.0 ± 17.1 46.4 ± 14.7
Table 4 Univariate and multivariate analysis of plasma AOPPs after operation for prediction of ALI
P < 0.10 in the univariate analysis were candidates for the multivariable logistic analysis (including variables: AOPPs 1 h after operation, Age, COPD, diabetes mellitus, 
hypertension, BMI and systolic BP)
ALI acute lung injury, Systolic BP systolic blood pressure
Univariate Multivariate
OR (95 % CI) P OR (95 % CI) P
AOPPs 1 h after operation 1.148 (1.065, 1.237) <0.001 1.164 (1.068, 1.269) 0.001
Age 1.103 (1.041, 1.168) 0.001 1.054 (0.984, 1.129) 0.130
COPD 9.615 (1.671, 55.314) 0.011 28.706 (1.770, 465.64) 0.018
Diabetes mellitus 10.20 (0.987, 105.38) 0.051 1.485 (0.085, 26.040) 0.787
Hypertension 8.167 (1.781, 37.449) 0.007 0.665 (0.059, 7.501) 0.741
BMI 1.147 (0.984, 1.336) 0.079 0.998 (0.758, 1.313) 0.989
Systolic BP 1.049 (1.001, 1.099) 0.052 1.061 (0.982, 1.147) 0.133
Fig. 3 ROC curve analysis of plasma levels of AOPPs measured at 1 h 
after operation. The area under the curve was 0.875 (95 % CI 0.774, 
0.942)
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Several potential limitations have to be acknowledged 
in our study. First, the results were obtained based on a 
relatively small sample size in one single center. Hence, 
a larger-cohort study is needed to verify these results. 
Second, traditional inflammatory cytokines were not 
quantitatively measured in this study. However, none of 
them was a specific biomarker for the occurrence of ALI 
post-CPB. Third, it is difficult to conclude that whether 
increased plasma levels of AOPPs are the cause of ALI 
or the consequence of major surgery which subsequently 
leads to ALI. However, due to the fact that perioperative 
characteristics did not significantly differ between the 
ALI and non-ALI groups, we believe that elevated plasma 
levels of AOPPs serve as a marker for the incidence after 
CPB. Specifically-designed study is required to further 
address this issue.
Conclusions
In conclusion, this is the first study identifying the poten-
tial role of AOPPs involved with the incidence of ALI fol-
lowing open cardiac surgery with the technique of CPB. 
We found that plasma levels of AOPPs could be used as 
an early biomarker of the occurrence of ALI after cardiac 
surgery with CPB in adult patients. The plasma levels 
of AOPPs are associated with lung function and clini-
cal outcome after CPB. The precise role of AOPPs in the 
clinical presentations and progression of ALI following 
cardiac surgery remain to be elucidated.
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